Masaki Murase

High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma

T. Yamashita, H. Iwasaki, J. Nishio, 2013, PloS one.

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas

T. Yamashita, N. Sato, T. Tsukahara, 2009, British Journal of Cancer.

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor

T. Yamashita, N. Sato, T. Tsukahara, 2009, Journal of Translational Medicine.

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma

T. Yamashita, S. Ichimiya, N. Sato, 2008, Cancer science.

Clonal T‐cell response against autologous pleomorphic malignant fibrous histiocytoma antigen presented by retrieved HLA‐A*0206

K. Ida, T. Yamashita, N. Sato, 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity

N. Sato, T. Hasegawa, Y. Tamura, 2011, Laboratory Investigation.

Autologous CTL response against cancer stem‐like cells/cancer‐initiating cells of bone malignant fibrous histiocytoma

T. Yamashita, N. Sato, T. Tsukahara, 2011, Cancer science.

SYT‐SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group

K. Ida, T. Yamashita, H. Tsuchiya, 2012, Cancer science.